Millipore Pharmaceutical Excipients Portfolio
| Brand | Millipore |
|---|---|
| Origin | USA |
| Supplier Type | Authorized Distributor |
| Import Status | Imported |
| Product Category | Pharmaceutical Excipients |
| Pricing | Available Upon Request |
Overview
Millipore Pharmaceutical Excipients Portfolio comprises a rigorously qualified range of high-purity, regulatory-compliant excipients designed for use in oral solid dosage forms, injectables, biologics formulations, and advanced drug delivery systems (DDS). These materials are manufactured under strict cGMP conditions and supported by comprehensive regulatory documentation—including Drug Master Files (DMFs), Certificates of Analysis (CoA), and compliance statements aligned with ICH Q5, Q7, and Q9 guidelines. The portfolio leverages Merck’s global pharmaceutical manufacturing infrastructure and quality systems, ensuring batch-to-batch consistency, traceability, and suitability for high-risk applications such as sterile parenterals and potent compound formulations.
Key Features
- Regulatory-ready excipients with full traceability from synthesis or purification through final packaging
- Extensive DMF support across major global regulatory jurisdictions (US FDA, EMA, PMDA, Health Canada)
- Comprehensive analytical characterization data including residual solvents (per ICH Q3C), elemental impurities (ICH Q3D), endotoxin levels (for injectables), and microbial limits (USP , )
- Specialized functional grades: Parteck® SRP 80 for direct compression sustained-release matrices; Parteck® MXP optimized for hot-melt extrusion (HME) processing; Parteck® SLC as a mesoporous silica carrier enhancing dissolution kinetics of BCS Class II/IV compounds
- Pharmaceutical-grade organic solvents (e.g., ethanol, isopropanol, ethyl acetate) meeting USP/NF and Ph. Eur. specifications for residual solvent control
Sample Compatibility & Compliance
The excipients are compatible with standard pharmaceutical unit operations including wet granulation, dry granulation, direct compression, spray drying, and lyophilization. All materials comply with compendial standards including United States Pharmacopeia (USP), European Pharmacopoeia (Ph. Eur.), and Japanese Pharmacopoeia (JP). For sterile applications, selected grades (e.g., mannitol, trehalose dihydrate, meglumine) are available with low endotoxin content (<0.25 EU/mg) and sterile filtration validation data. Compendial compliance is verified per relevant monographs (e.g., USP Analytical Instrument Qualification for supporting analytical methods used in release testing).
Software & Data Management
While excipients themselves do not incorporate embedded software, Millipore provides digital regulatory dossiers via the Merck Regulatory Support Portal—enabling secure, audit-ready access to CoAs, stability data, extractables/leachables profiles, and DMF cross-references. All documentation adheres to ALCOA+ principles (Attributable, Legible, Contemporaneous, Original, Accurate, Complete, Consistent, Enduring, Available) and supports 21 CFR Part 11-compliant electronic record workflows when integrated with validated laboratory information management systems (LIMS) or quality management systems (QMS).
Applications
- Mannitol and Parteck® sorbitol as bulking agents and fillers in chewable tablets and orodispersible films
- Trehalose and meglumine as stabilizers in lyophilized biologics and mRNA vaccine formulations
- Anhydrous dibasic calcium phosphate (DCP) as a high-density, low-moisture excipient for moisture-sensitive APIs
- Parteck® SRP 80 enabling matrix-based extended-release profiles without polymer blending complexity
- Parteck® MXP providing thermoplastic processability and API dispersion stability during HME-based amorphous solid dispersion development
- Parteck® SLC facilitating rapid dissolution of poorly water-soluble drugs via capillary-driven loading and surface area amplification
- Pharmaceutical-grade preservatives (e.g., benzyl alcohol, phenol) and sweeteners (e.g., sucralose) qualified for multi-dose injectables and pediatric oral solutions
FAQ
Are Millipore pharmaceutical excipients supplied with full regulatory documentation?
Yes—each lot is accompanied by a Certificate of Analysis, Certificate of Compliance, and, where applicable, DMF access letters. Regulatory support packages are available upon request for pre-submission alignment.
Can Parteck® excipients be used in GMP manufacturing environments?
All Parteck® grades are manufactured at ISO 9001- and ISO 13485-certified facilities operating under cGMP principles compliant with 21 CFR Parts 210/211 and EU Annex 1 for sterile products.
Is stability data available for long-term storage of these excipients?
Stability studies (real-time and accelerated) are conducted per ICH Q1A(R2) and summarized in technical bulletins accessible via the Merck Excipients Resource Center.
Do you provide extractables and leachables data for packaging compatibility assessment?
Yes—comprehensive extractables profiling (per USP and ) is available for primary packaging contact studies, including glass vials, polyolefin containers, and elastomeric closures.
How are elemental impurities controlled in these excipients?
All excipients undergo rigorous ICH Q3D-compliant elemental impurity screening using ICP-MS, with results reported in CoAs against permitted daily exposure (PDE) thresholds.
